Paradoxical bronchodilator response is associated with increased risk of asthma exacerbations
J Allergy Clin Immunol Pract
.
2024 Mar 26:S2213-2198(24)00290-3.
doi: 10.1016/j.jaip.2024.03.028.
Online ahead of print.
Authors
Battoul Fakhry
1
,
Celine Chedraoui
1
,
Joelle Sleiman
1
,
Amy Attaway
1
,
Tara Carr
2
,
Benjamin Gaston
3
,
Bo Hu
1
,
Deborah Meyers
4
,
Victor E Ortega
4
,
Eugene R Bleecker
4
,
Joe Zein
5
Affiliations
1
Lerner Research Institute and Respiratory Institute, Cleveland Clinic, Cleveland, Ohio.
2
Department of Medicine, University of Arizona, Tucson, Ariz.
3
Department of Pediatrics, Indiana University, Indianapolis, Ind.
4
Department of Medicine, Mayo Clinic, Scottsdale, Ariz.
5
Department of Medicine, Mayo Clinic, Scottsdale, Ariz. Electronic address: Zein.Joe@mayo.edu.
PMID:
38548172
DOI:
10.1016/j.jaip.2024.03.028
No abstract available
Grants and funding
P01 HL158507/HL/NHLBI NIH HHS/United States
R01 HL161674/HL/NHLBI NIH HHS/United States